72301837
voted
Given the extensive updates and technological innovations expected at NVIDIA's GTC 2025, coupled with historical data suggesting a high likelihood of $NVIDIA (NVDA.US)$'s stock price increasing during such events, a strategic approach to options trading can be particularly beneficial. Here's an integrated strategy that leverages both the expected technological announcements and historical stock performance.
Introduction
$NVIDIA (NVDA.US)$'s premier...
+6
108
23
14
72301837
Set a live reminder
$NVIDIA (NVDA.US)$
NVIDIA Q4 FY2025 earnings conference call is scheduled for February 26 at 5:00 PM EDT /February 27 at 6:00 AM SGT /February 27 at 9:00 AM AEDT. Subscribe to join the live earnings conference with management NOW!
Beat or Miss?
What do you expect from NVIDIA's Q4 earnings? Will the company beat or miss the estimates? Make sure to click the "Book" button to get what management has to say!
Disclaimer:
This presentation is for information ...
NVIDIA Q4 FY2025 earnings conference call is scheduled for February 26 at 5:00 PM EDT /February 27 at 6:00 AM SGT /February 27 at 9:00 AM AEDT. Subscribe to join the live earnings conference with management NOW!
Beat or Miss?
What do you expect from NVIDIA's Q4 earnings? Will the company beat or miss the estimates? Make sure to click the "Book" button to get what management has to say!
Disclaimer:
This presentation is for information ...
NVIDIA Q4 FY2025 earnings conference call
Feb 27 06:00
1108
573
55
72301837
liked
$Tempest Therapeutics (TPST.US)$
Tempest Therapeutics’ PPARalpha inhibitor receives FDA orphan designation
is this a good news![]()
Tempest Therapeutics’ PPARalpha inhibitor receives FDA orphan designation
is this a good news
3
72301837
liked
Why Tempest Therapeutics Inc. ( $Tempest Therapeutics (TPST.US)$ ) is a good buy:
1. Innovative Pipeline: TPST is a clinical-stage biotechnology company focused on developing small molecule therapeutics for cancer treatment. Their leading programs, TPST-1495 and TPST-1120, are in Phase 1 trials targeting various tumors.
2. Strategic Partnerships: The company has a collaboration with Roche to advance TPST-1120 in combination with other therapies...
1. Innovative Pipeline: TPST is a clinical-stage biotechnology company focused on developing small molecule therapeutics for cancer treatment. Their leading programs, TPST-1495 and TPST-1120, are in Phase 1 trials targeting various tumors.
2. Strategic Partnerships: The company has a collaboration with Roche to advance TPST-1120 in combination with other therapies...
6
1
1
72301837
commented on
$NVIDIA (NVDA.US)$ 130 zone when market open huge sellofff
3
4
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
72301837
voted
Good morning, traders. Happy Friday, September 6th. The market declined Friday morning, ending a short but volatile week for stocks: September started with a pullback. The S&P 500 fell below the historic 5,500 point mark Thursday, a level reached in June, broken through with an August pullback, and now hit again in the first sessions of September.
My name is Kevin Travers; here is a round-up of stories moving on the U.S. stock marke...
My name is Kevin Travers; here is a round-up of stories moving on the U.S. stock marke...
38
10
2
72301837
voted
Happy Friday mooers!
![]()
What do you think of Nvidia's Q2 earnings? Unlock insights with NVDA Earnings Hub>>
Our Canadian mooer @SpeedyStud shared thoughts like:
![]()
Well, they beat, but...
$NVIDIA (NVDA.US)$ surpassed Q2 earnings projections on August 28, but the stock declined following the announcement.![]()
The company posted an adjusted EPS of $0.68 per share and revealed a $50 billion share repurchase plan. Revenue re...
Our Canadian mooer @SpeedyStud shared thoughts like:
$NVIDIA (NVDA.US)$ surpassed Q2 earnings projections on August 28, but the stock declined following the announcement.
32
12
1
![[empty]](https://static.moomoo.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://static.moomoo.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)
![[loading]](data:image/svg+xml;base64,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)